Tags |
|
|
Links |
|
|
Write You - Abatement Progress Charting
Often we have a problem in our civilization, which involves abatement
According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
procedures of a substance, pest, insect or challenge. The most importa
; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.
Examples of combination products may in
Examples of combination products may in
t thing is to clearly define a timetable to set of goals to adequately
lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.
chart the progress. Today with sophisticated sensors, ERSI 3D trackin
here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
and technological advances we can more easily monitor our progress to
d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.
Combination pro
Combination pro
see if we are on track to accomplishing our objectives in the abatemen
ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
t process.
However, what I commonly see is that in many issues where
However, what I commonly see is that in many issues where
easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
t really matters we are not tracking such things; why? For instance af
nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
ter 911 there were issues with air quality and bad particles in the ai
and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
and now 19,000 seem to have the “9-11 Death Cough” and many have alre
ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
dy died and 10’s of thousands more are expected to die.
In New Orlean
In New Orlean
ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.
Following aspects would a
Following aspects would a
s the Lake Pontchartrain is completely filled with really gross toxins
dd to the challenges in developing combination products:
Which markets to tap where the combination products can do fairly well?
Which combination prod
Which markets to tap where the combination products can do fairly well?
Which combination prod
and pollutions and it will take some time for the lake to fully recove
cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
r in many areas where the lake does not circulate well. Meanwhile with
tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
n the soup bowl itself free-standing water and swimming pools have hug
t?
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
amounts of biological bacteria breeding scum ponds and the Mosquitoes
ping new procedures for reviewing their safety, efficacy and quality.
Professional from academic institutions, pharmaceutical industries, health care indust
Professional from academic institutions, pharmaceutical industries, health care indust
are having a field day.
Are things getting better or worse as Hurric
Are things getting better or worse as Hurric
y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
ne Season comes around again? You can see why it is essential to have
.
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
abatement procedures carefully charted to insure forward progress and
elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.
Companies that provide selfless information through particip
Companies that provide selfless information through particip
ot back sliding or exacerbation of the problems. Consider this in 2006
tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.writeyou.org.ua/article/192914/writeyou-Abatement-Progress-Charting.html">Abatement Progress Charting</a>
BB link (for phorums):
[url=http://www.writeyou.org.ua/article/192914/writeyou-Abatement-Progress-Charting.html]Abatement Progress Charting[/url]
Related Articles:
If You Build It They Will Come...Well Sort Of; What I Learned As a Newbie Webmaster
Selecting a Great Full-Service Stock Broker
Benefits of Using a Small Mortgage Company
Bookmark it:
|